Atlas Trials

A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients

Clinical trial NCT05487248 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05487248
Sponsor
Jules Bordet Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Unresectable Locally Advanced Colorectal CancerMetastatic Colorectal CancerCandidate for Third-line or Subsequent Lines of Therapy
Start date
2023-10-12
Primary completion
2026-09-30
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.